Zobrazeno 1 - 6
of 6
pro vyhledávání: '"K. A. Kuzin"'
Autor:
K. I. Kirsanov, K. A. Kuzin, T. I. Fetisov, E. A. Lesovaya, G. A. Belitskiy, M. G. Yakubovskaya
Publikováno v:
Сибирский онкологический журнал, Vol 19, Iss 3, Pp 122-136 (2020)
The purpose of the study was to analyze the existing methodological approaches to the experimental testing of resistance to chemotherapy and assess the prospects for their further application.Material and Methods. We analyzed publications regarding t
Externí odkaz:
https://doaj.org/article/98b1ea96f5dc4b47bfe5bfd8784b0782
Autor:
K. A. Kuzin, T. I. Fetisov, R. I. Knyazev, L. Ya. Fomina, L. V. Meheda, E. A. Lesovaya, G. A. Belitsky, M. G. Yakubovskaya, K. I. Kirsanov
Publikováno v:
Успехи молекулярной онкологии, Vol 6, Iss 4, Pp 8-25 (2019)
Objectives: to provide a rationale for existing approaches for the evaluation of chemoresistance of ovarian cancer in vitro, to perform a comparative analysis of the methods and to assess the perspectives of their further application.Materials and me
Externí odkaz:
https://doaj.org/article/e1118a9a164e4969b74e1580da5ee8f1
Autor:
A. V. Savinkova, E. M. Zhidkova, L. R. Tilova, M. D. Lavrova, E. S. Lylova, K. A. Kuzin, A. Yu. Portyannikova, V. P. Maximova, A. V. Kholodova, O. A. Vlasova, T. I. Fetisov, K. I. Kirsanov, G. A. Belitskiy, M. G. Yakubovskaya, E. A. Lesovaya
Publikováno v:
Сибирский онкологический журнал, Vol 17, Iss 3, Pp 77-87 (2018)
Recently many new approaches for repurposing or repositioning of the clinically used drugs have been developed. Drug repurposing allows not only to use known schemes for the synthesis of biologically active compounds, but also to avoid multiple studi
Externí odkaz:
https://doaj.org/article/e9faacf944904ba39f5c4fc1143a98e4
Autor:
E. M. Zhidkova, K. A. Kuzin, L. R. Tilova, A. V. Savinkova, O. I. Borisova, M. D. Lavrova, V. P. Maximova, K. I. Kirsanov, M. G. Yakubovskaya, E. A. Lesovaya
Publikováno v:
Сибирский онкологический журнал, Vol 16, Iss 6, Pp 41-46 (2017)
Glucocorticoids (GCs) are often used as an adjuvant therapy to reduce the adverse effects of chemotherapy in breast cancer patients. Moreover, GCs can display pro-proliferative or anti-proliferative effects on BC cells depending on their molecular su
Externí odkaz:
https://doaj.org/article/4d64a0da2fe24c45b32fe739585c115d
Autor:
K. A. Kuzin, K. I. Kirsanov, O. I. Borisova, Irina Budunova, E. M. Zhidkova, L. R. Tilova, A. V. Savinkova, M. G. Yakubovskaya, G. A. Belitsky, E. A. Lesovaya
Publikováno v:
Russian Journal of Biotherapy. 16:61-69
Introduction. Glucocorticoids are the important component of combined chemotherapy of blood cancer. Therapeutic effects of glucocorticoids is realized via activation of glucocorticoid receptor transrepression, the development of side effects is assoc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3556c6e303e99fc0a14cffc484fef17e
https://doi.org/10.17650/1726-9784-2017-16-1-61-69
https://doi.org/10.17650/1726-9784-2017-16-1-61-69
Autor:
T. I. Fetisov, Kirill I. Kirsanov, A. V. Savinkova, E. M. Zhidkova, Ekaterina A. Lesovaya, K. A. Kuzin, AS Antipova, L. R. Tilova, OA Vlasova, O. I. Borisova, OYu Baranova, Marianna G. Yakubovskaya, GA Belitskii
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 10, Iss 2, Pp 235-249 (2017)
Hematological disorders include a wide spectrum of malignancies of hematopoietic and lymphoid tissues. The genetic changes underlying the pathogenesis of the diseases are specific for each disease. High incidence of chromosomal aberrations (deletion,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87045939e75d134f2751d62ffb3f35d9
https://doi.org/10.21320/2500-2139-2017-10-2-235-249
https://doi.org/10.21320/2500-2139-2017-10-2-235-249